Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly P-FL versus every-3-week PF neoadjuvant chemotherapy for advanced nasopharyngeal carcinoma
ChiCTR-IPR-15006378Phase 3Not yet recruiting
- Sponsor
- Fujian Medical University Cancer Hospital
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of cisplatin and fluorouracil in nasopharyngeal carcinoma (NPC) (2 arms), sponsored by Fujian Medical University Cancer Hospital. Primary endpoint: Acute toxicity reaction. Planned start Jul 2015; status: not yet recruiting.
02
Drugs
cisplatinfluorouracil
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on ChiCTR-IPR-15006378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15006378.